RecruitingNCT05292235
Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
Sponsor
Chinese University of Hong Kong
Enrollment
2,000 participants
Start Date
Apr 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective data registry to assess the treatment outcomes and complications of different treatment approaches in our hospital clusters.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria1
- Patient at the age of 18 or above
Exclusion Criteria1
- Patient is unable to give consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05292235
Related Trials
BPH Global Registry
NCT0554320026 locations
Ambulatory Long Length URodynamics Evaluation
NCT074250157 locations
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT0651114120 locations
The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy
NCT072146751 location
Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction
NCT0557424417 locations